Dolutegravir 25 mg and 50 mg and OnabotulinumtoxinA Injection
Determining the interaction of Dolutegravir 25 mg and 50 mg and OnabotulinumtoxinA Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dolutegravir
Brand name: Tivicay
Synonyms: Dolutegravir
Generic Name: onabotulinumtoxinA
Brand name: Botox, Botox Cosmetic
Synonyms: OnabotulinumtoxinA
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dolutegravir 25 mg and 50 mg-Onabotulinumtoxina Intramuscular
- Dolutegravir 25 mg and 50 mg-Onasemnogene Abeparvovcec Infusion
- Dolutegravir 25 mg and 50 mg-Onasemnogene Abeparvovec
- Dolutegravir 25 mg and 50 mg-Onasemnogene abeparvovec Zolgensma
- Dolutegravir 25 mg and 50 mg-Oncaspar
- Dolutegravir 25 mg and 50 mg-Oncovin
- OnabotulinumtoxinA Injection-Dolutegravir and lamivudine
- OnabotulinumtoxinA Injection-Dolutegravir and rilpivirine
- OnabotulinumtoxinA Injection-Dolutegravir Sodium
- OnabotulinumtoxinA Injection-Dolutegravir Sodium And Lamivudine
- OnabotulinumtoxinA Injection-Dolutegravir Sodium and Rilpivirine Hydrochloride
- OnabotulinumtoxinA Injection-Dom-Etoposide